3-hydroxyanthranilic acid has been researched along with Schizophrenia in 3 studies
3-Hydroxyanthranilic Acid: An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.
3-hydroxyanthranilic acid : An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan.
3-hydroxyanthranilate : A hydroxybenzoate that is the conjugate base of 3-hydroxyanthranilic acid.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To develop a method for determining cinnabarinic acid (CA) and its immediate precursor 3-hydroxyanthranylic acid (3HAA) in blood plasma and to study their concentrations in patients with schizophrenia before and after treatment." | 8.12 | [Cinnabarinic acid as a potential prognostic marker of schizophrenia]. ( Baymeeva, NV; Brusov, OS; Oleichik, IV; Shilov, YE; Sizov, SV; Tyurin, IA, 2022) |
| "Increased concentrations of kynurenine pathway metabolites have been reported by several groups for disorders involving psychosis, including schizophrenia and bipolar disorder." | 7.74 | Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. ( Cwik, M; Llenos, IC; Miller, CL; Walkup, J; Weis, S, 2008) |
| "To develop a method for determining cinnabarinic acid (CA) and its immediate precursor 3-hydroxyanthranylic acid (3HAA) in blood plasma and to study their concentrations in patients with schizophrenia before and after treatment." | 4.12 | [Cinnabarinic acid as a potential prognostic marker of schizophrenia]. ( Baymeeva, NV; Brusov, OS; Oleichik, IV; Shilov, YE; Sizov, SV; Tyurin, IA, 2022) |
| "Increased concentrations of kynurenine pathway metabolites have been reported by several groups for disorders involving psychosis, including schizophrenia and bipolar disorder." | 3.74 | Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. ( Cwik, M; Llenos, IC; Miller, CL; Walkup, J; Weis, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shilov, YE | 1 |
| Baymeeva, NV | 1 |
| Brusov, OS | 1 |
| Oleichik, IV | 1 |
| Sizov, SV | 1 |
| Tyurin, IA | 1 |
| Möller, M | 1 |
| Du Preez, JL | 1 |
| Harvey, BH | 1 |
| Miller, CL | 1 |
| Llenos, IC | 1 |
| Cwik, M | 1 |
| Walkup, J | 1 |
| Weis, S | 1 |
3 other studies available for 3-hydroxyanthranilic acid and Schizophrenia
| Article | Year |
|---|---|
[Cinnabarinic acid as a potential prognostic marker of schizophrenia].
Topics: 3-Hydroxyanthranilic Acid; Female; Humans; Kynurenine; Oxazines; Prognosis; Schizophrenia | 2022 |
Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Topics: 3-Hydroxyanthranilic Acid; Animals; Charcoal; Chromatography, High Pressure Liquid; Depression; Kynu | 2012 |
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Topics: 3-Hydroxyanthranilic Acid; Adult; Biomarkers; Bipolar Disorder; Brain; Chromatography, High Pressure | 2008 |